viable cell source
appropriate cell source
vascular grafts Tissue
vascular bypass
TEVG cell source
vascular interposition
LAF cells
efficient cellular source
cell stability
regenerative TEVGs
morphological characterisation of human diseased vascular tissue
capacity of LAF derived cells
numerous issues
non-patent vascular segments
small animal model
grafts ability
study
numerous regulatory issues
Investigation
fellowship
viability
production of small diameter tissue
appropriate human size
large animal model
favourable cellular behaviour
Prof Fergal O’Brien’s Lab
Prof David Vorp’s Lab
return phase
outgoing phase
lipoaspirate fluid
field of regenerative medicine
existing repertoire of research
professional research career
manipulated liposuction aspirate fluid
University of Pittsburgh
high levels of manipulation
technique unviable
great promise
environment
scaling
Royal College of Surgeons
clinical setting
digestion
biodegradable scaffold
growing burden of cardiovascular disease
way
clinicians
isolation
complementary skills
use
processing costs
true potential
culture
Ireland
aim
PhD
Treatment